Journal of Pediatric Neurology 2010; 08(04): 421-424
DOI: 10.3233/JPN-2010-0424
Georg Thieme Verlag KG Stuttgart – New York

Posterior reversible encephalopathy syndrome in Henoch-Schonlein purpura induced by oral steroid therapy and hypertension

Evangelos Pavlou
a   2nd Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Maria Hatzistilianou
a   2nd Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Maria Stamou
a   2nd Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Liana Fidani
a   2nd Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Afrodites Charitandi
a   2nd Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
,
Fani Athanasiadou
a   2nd Department of Pediatrics, Aristotle University of Thessaloniki, Thessaloniki, Greece
› Author Affiliations

Subject Editor:
Further Information

Publication History

09 February 2009

24 July 2009

Publication Date:
30 July 2015 (online)

Abstract

An 11-year-old boy with Henoch-Schonlein purpura complicated by hypertension-induced encephalopathy is reported. Steroid therapy (oral prednisolone 2 mg/kg per day) was started immediately after diagnosis because of gastrointestinal involvement. A few days later the patient developed hypertension followed by generalized tonic-clonic seizures. A peripheral lesion in the posterior gray and white matter was seen on magnetic resonance imaging. The nature and location of the lesions and the normalization of the patient's magnetic resonance imaging reported a few months later was consistent with a posterior predominant parieto-occipital encephalopathy described in the literature as posterior reversible encephalopathy syndrome. The occurrence of this very rare syndrome in childhood requires close monitoring and normalization of blood pressure in patients in order to prevent central nervous system manifestations.